Venous Leg Ulcers (Crural ulcer):グローバル臨床試験レビューH1, 2013...市場調査レポートについてご紹介

【英文タイトル】Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Venous Leg Ulcers (Crural ulcer) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Venous Leg Ulcers (Crural ulcer) 25
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Venous Leg Ulcers (Crural ulcer) Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Healthpoint Biotherapeutics 34
Clinical Trial Overview of Healthpoint Biotherapeutics 34
Nitric Biotherapeutics, Inc. 35
Clinical Trial Overview of Nitric Biotherapeutics, Inc. 35
Pergamum AB 36
Clinical Trial Overview of Pergamum AB 36
CoDa Therapeutics, Inc. 37
Clinical Trial Overview of CoDa Therapeutics, Inc. 37
DermaTools Biotech GmbH 38
Clinical Trial Overview of DermaTools Biotech GmbH 38
Phoenix Eagle Company Pty Ltd 39
Clinical Trial Overview of Phoenix Eagle Company Pty Ltd 39
Altrika Ltd 40
Clinical Trial Overview of Altrika Ltd 40
Kringle Pharma, Inc. 41
Clinical Trial Overview of Kringle Pharma, Inc. 41
FirstString Research, Inc. 42
Clinical Trial Overview of FirstString Research, Inc. 42
HealOr Ltd. 43
Clinical Trial Overview of HealOr Ltd. 43
Skingenix, Inc. 44
Clinical Trial Overview of Skingenix, Inc. 44
AUS Bio Limited 45
Clinical Trial Overview of AUS Bio Limited 45
National Healing Corporation 46
Clinical Trial Overview of National Healing Corporation 46
Smith & Nephew, Inc. 47
Clinical Trial Overview of Smith & Nephew, Inc. 47
MiMedx Group, Inc 48
Clinical Trial Overview of MiMedx Group, Inc 48
RegeneRx Biopharmaceuticals, Inc. 49
Clinical Trial Overview of RegeneRx Biopharmaceuticals, Inc. 49
Linde Gas Therapeutics GmbH 50
Clinical Trial Overview of Linde Gas Therapeutics GmbH 50
NovaBay Pharmaceuticals, Inc. 51
Clinical Trial Overview of NovaBay Pharmaceuticals, Inc. 51
Tissue Therapies Limited 52
Clinical Trial Overview of Tissue Therapies Limited 52
Regenerative Medicine Assets Limited (Inactive) 53
Clinical Trial Overview of Regenerative Medicine Assets Limited (Inactive) 53
Clinical Trial Overview of Top Institutes / Government 54
Department of Health, South Africa 54
Clinical Trial Overview of Department of Health, South Africa 54
Medical University of South Carolina 55
Clinical Trial Overview of Medical University of South Carolina 55
University of Pennsylvania 56
Clinical Trial Overview of University of Pennsylvania 56
Monash University 57
Clinical Trial Overview of Monash University 57
U.S. Department of Veterans Affairs 58
Clinical Trial Overview of U.S. Department of Veterans Affairs 58
VU University Medical Center 59
Clinical Trial Overview of VU University Medical Center 59
Atlantic Health System 60
Clinical Trial Overview of Atlantic Health System 60
The Ohio State University 61
Clinical Trial Overview of The Ohio State University 61
Ulster Hospital 62
Clinical Trial Overview of Ulster Hospital 62
Centre Hospitalier Universitaire, Amiens 63
Clinical Trial Overview of Centre Hospitalier Universitaire, Amiens 63
Carlos III Health Institute 64
Clinical Trial Overview of Carlos III Health Institute 64
Department of Health, UK 65
Clinical Trial Overview of Department of Health, UK 65
Faculdade Evangelica do Parana 66
Clinical Trial Overview of Faculdade Evangelica do Parana 66
Fundacion Iberoamericana Itaca 67
Clinical Trial Overview of Fundacion Iberoamericana Itaca 67
Basque Health Service 68
Clinical Trial Overview of Basque Health Service 68
Aston University 69
Clinical Trial Overview of Aston University 69
Pennine Acute Hospitals NHS Trust 70
Clinical Trial Overview of Pennine Acute Hospitals NHS Trust 70
Royal College of Surgeons Ireland 71
Clinical Trial Overview of Royal College of Surgeons Ireland 71
Hospital De Clinicas 72
Clinical Trial Overview of Hospital De Clinicas 72
West Penn Allegheny Health System 73
Clinical Trial Overview of West Penn Allegheny Health System 73
Five Key Clinical Profiles 74
Appendix 103
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Disclaimer 105
Source 106


【レポート販売概要】

■ タイトル:Venous Leg Ulcers (Crural ulcer):グローバル臨床試験レビューH1, 2013
■ 英文:Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013
■ 発行日:2013年6月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161322
■ 調査対象地域:グローバル
  • 建設用重ダンプトラックの世界市場2017-2021
    ABSTRACTAbout Construction Dumper A construction dumper is defined as the medium used to transport loose materials such as sand, gravel, aggregates, and others for construction purposes. A construction dumper has an open bed box at the rear end of the dump truck; it has a hydraulic piston, which lifts the hauler or trailer to dump the required material onto the ground. A construction dumper is def …
  • インテリジェントRFIDプラットフォームの世界市場2017-2021
    About Intelligent RFID Platform An intelligent RFID platform is basically a part of RFID middleware that enables the development and deployment of RFID systems. The intelligent RFID platform absorbs differences in different RFID tags from multiple suppliers. It then integrates the data to build scalable and flexible RFID solutions. The intelligent RFID platform has tools for monitoring and maintai …
  • MVNO事業計画(MVNO Business Plan)
    This is a full business plan based on the launch of an illustrative Mobile Virtual Network Operator (MVNO) known as Contendus. The plan covers all aspects of the company launch plan including market assessment, funding requirements, financial analysis, market segmentation and product differentiation. Also included is go-to-market plan, distribution and replenishment plans, comparison of MVNO's and …
  • アミラーゼの市場別検査数および販売予測(2013-2018/体外診断/世界主要国)
    This new report from Venture Planning Group provides analysis of Amylase testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing   - Hospitals - Commercial/Private Laboratories POC …
  • ICT調達動向:小売産業部門 – 企業のICT投資計画
    Why was the report written? To highlight the criteria on which retailers select their ICT providers as well as the roles which have influence while making ICT purchasing decisions. What is the current market landscape and what is changing? Retailers favour the deployment of almost all technologies on-premise; however the adoption of hosted services is also gaining momentum. What are the key driver …
  • コレステロールスクリーニング/コレステロール臨床試験の世界市場予測(~2021):サービス利用者別(医師/医療提供者、病院、雇用主、医療制度、MCO、政府、ACO、IDN総合医療ネットワーク、患者)、地域別(北米、ヨーロッパ)、定性的評価
    The global cholesterol testing services market is expected to reach USD 17.5 billion by 2021 from USD 11.9 billion in 2016, growing at a CAGR of 8% during the forecast period. This market is segmented on the basis of type of customer and region. Based on type of customer, the market is segmented into physicians/providers and hospitals; employers, health plans, and Managed Care Organizations (MCOs) …
  • 種子の世界市場:穀物種子、脂肪種子、野菜種子
    About Seeds Seed is the most basic unit for cultivation of crops. It is a fertilized ripened ovule, capable of reproducing and developing into a plant. Seeds include cereals, pulses, vegetables, and fruits. Innovations in technology have improved the quality of seeds and provided a wide variety with desired characteristics and suited to specific conditions and geographies. This development is nece …
  • マネージド・ネットワーク・サービスの世界市場:設計、導入、モニタリング、サポート・メンテナンスサービス
    The companies always go through a tight financial budget during an economic slowdown. The unwanted expenses are supposed to the cut down by the companies to avoid financial loss. The reduction in operational costs is the main to the enterprise during slack in the economic condition. The IT department of the companies handle’s the network by the traditional method that is, in-house network services …
  • 世界のバイオ技術市場
    Biotechnology has become the foundation on which the pharmaceutical industry and many others are progressing on. The biotech revolution has surpassed the IT revolution as well and has become the new engine of the global economy. The products derived through biotechnology have altered the landscape of many industries, particularly pharmaceuticals. The completion of the Human Genome Project has been …
  • 水性エポキシ樹脂の世界市場:用途、需要先、地域別分析
    Waterborne epoxy resins exhibit high stability and excellent dilution efficiency. The waterborne epoxy resins offer different functionalities for a variety of applications such as automotive, construction, textiles, furniture and packaging. The aqueous epoxy resins include non-ionic epoxy-functional emulsifiers, which allow the emulsifier to become a part of the cured product with minimal impact o …
  • Bonterra Energy Corp:石油・ガスバリューチェーン分析レポート2013
    Bonterra Energy Corp Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Bonterra Energy Corp" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Bonterra Energy Corp”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report exam …
  • 特発性肺線維症(Idiopathic Pulmonary Fibrosis):治療薬開発パイプライン動向(2015年上半期版)
    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Idiopathic Pulmonary Fibrosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Idiopathic Pulmonary Fibrosis, complete with comparative analysis at various stages, t …
  • グローバル画像診断装置(医療機器)メーカー分析(技術能力、戦略、課題):Shimadzu
    The strategic assessment of Shimadzu, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in …
  • 水処理用化学薬品(WTC)の世界市場:腐食防止剤、スケール防止剤、凝固剤、凝集剤、殺生物剤、消毒剤
    The global water treatment chemicals market size, in terms of value, is projected to reach USD 24.94 Billion by 2020, registering a CAGR of 4.53% between 2015 and 2020. The increasing demand of water treatment chemicals from end-use industries such as municipal water treatment, oil & gas, power generation, metal & mining, and chemical processing due to its superior properties and cost savings is t …
  • PTFE膜の世界市場2017-2021
    About PTFE Membrane PTFE is a polymer composed of carbon and fluorine. PTFE has a straight, long carbon backbone to which the fluorine atoms are bonded. The carbon backbone is protected by the electron cloud of fluorine atoms that form a uniform helical sheath. Therefore, it forms strong bonds, and the non-polarity of PTFE makes it extremely inert and thermally stable. Technavio’s analysts forecas …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。